CXCR2 and ovarian cancer: In spite of no change in EGFR activation after cancer spreading of SKA and SKCXCR2 cells, the NF-κB signaling pathway appears to conserve CXCR2-driven ovarian cancer progression throughout the whole process including initiation, promotion and progression phases.